Selected Grants
Drug Development of Skp2 PROTACs in Cancer (1 R01 CA277682-01)
ResearchPrincipal Investigator · Awarded by University of Texas Health Science Center at San Antonio · 2023 - 2028Identification of a novel targetable cancer stem cell regulator promoting cancer progression and metastasis in non-small cell lung cancer
ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2023 - 2028Unravel a novel metabolic pathway orchestrating prostate cancer progression and therapeutic resistance
ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2023 - 2027Regulation of oncogenic Akt ubiquitination and activation by diverse mechanisms in cancer
ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2023 - 2026External Relationships
- Academia Sinica, Taiwan
- Chang Gung University of Science and Technology
- Institute of Biomedical Sciences at Academia Sinica, Taiwan
- Ministry of Health and Welfare
- Ministry of education, Taiwan
- National Science and Technology Council, Taiwan
- Stablix, Inc
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.